News
Suriname developed a high quality plasma COVID-19 treatment procedure that is more cost efficient than European methods
The Academic Medical Center (AZP) in Paramaribo, Suriname, successfully studied an efficient method to collect COVID-19 antibody-containing plasma from recovered Covid-19 patients to treat critically ill patients. In contrast with prevailing plasma donation strategies, the Academic Medical Center collects...
News
Digital transformation starts with an attitude says pharmaceutical service provider
The key to digital transformation has been indelibly linked to the latest technology. However more often, what we find is that it’s certainly not a case of bolting on a few digital channels to your existing traditional model, and...
Clinical Trials
INOVIO Reports FDA Partial Clinical Hold for Planned Phase 2 / 3 Trial of COVID-19 Vaccine Candidate INO-4800
INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, announced that the U.S. FDA has notified the company it has additional questions about the company's...
News
Centus Biotherapeutics Receives European Marketing Authorization for Equidacent, Biosimilar Avastin
Centus Biotherapeutics Ltd., a joint venture between Fujifilm Kyowa Kirin Biologics Co., Ltd. and AstraZeneca, announced that the European Commission (EC) has granted the marketing authorization for Equidacent® (Product Code: FKB238), the company's biosimilar to Avastin® (bevacizumab).
The authorization follows...
Clinical Trials
Genetron, CStone start clinical trial in China to develop CDx for avapritinib
Genetron and its partner CStone Pharmaceuticals have commenced a clinical trial in China, to jointly develop a companion diagnostic (CDx) test for avapritinib.
Discovered by Blueprint Medicines, Avapritinib is a US Food and Drug Administration (FDA) approved kinase inhibitor, to...
News
High Purity New England Supports Drug Development Pipelines with Fully Customizable and Flexible Single-Use Assembly Solution
Demand for single-use assembly solutions in the biopharma industry continues to increase, with the market expected to be worth $26.89 billion by 2025.
To help meet that demand, High Purity New England (HPNE), a leading supplier of biopharma equipment and...
News
Sterling Pharma Solutions acquires API facility in the US
Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has announced its acquisition of Alcami’s Germantown, Wisconsin facility in the US.
The new facility will further bolster Sterling’s US presence and will provide additional capacity for customer API development...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read